Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214584771> ?p ?o ?g. }
- W4214584771 endingPage "775" @default.
- W4214584771 startingPage "765" @default.
- W4214584771 abstract "Non-small-cell lung carcer (NSCLC), the main histological subtype of lung cancer, is responsible for significant morbidity and mortality worldwide. Telocinobufagin, an active compound of the Chinese traditional medicine ChanSu, has antitumor effects, but its mechanism of action remains unknown. Therefore, we investigated the effect of telocinobufagin on NSCLC growth and metastasis and its possible mechanism of action, in vitro and in vivo. Cell proliferation, migration, and apoptosis were measured by methyl thiazol tetrazolium assay, colony formation, 5-ethynyl-2'-deoxyuridine incorporation, Transwell migration, wound healing, and flow cytometry analysis. A mouse xenograft model was used to evaluate tumor formation in vivo. Telocinobufagin was found to suppress proliferation and metastasis and induce apoptosis in human NSCLC cells. Moreover, telocinobufagin was able to significantly inhibit STAT3 phosphorylation at tyrosine 705 (Y705) and its downstream targets. Additionally, telocinobufagin also impaired the IL-6-induced nuclear translocation of STAT3. Consistent with the in vitro experiments, telocinobufagin reduced the A549 xenograft tumor burden and the levels of P-STAT3Y705, MCL1, BCL2, and cleaved PARP1 in vivo. These results support telocinobufagin as a promising STAT3 signaling inhibitor candidate for the treatment of NSCLC patients." @default.
- W4214584771 created "2022-03-02" @default.
- W4214584771 creator A5018720472 @default.
- W4214584771 creator A5024319971 @default.
- W4214584771 creator A5045399243 @default.
- W4214584771 creator A5050935789 @default.
- W4214584771 creator A5052403623 @default.
- W4214584771 creator A5057226699 @default.
- W4214584771 creator A5065499122 @default.
- W4214584771 creator A5066954860 @default.
- W4214584771 creator A5070696076 @default.
- W4214584771 creator A5075295556 @default.
- W4214584771 creator A5075828120 @default.
- W4214584771 date "2022-02-24" @default.
- W4214584771 modified "2023-10-14" @default.
- W4214584771 title "Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling" @default.
- W4214584771 cites W1812164980 @default.
- W4214584771 cites W1814610372 @default.
- W4214584771 cites W1969324158 @default.
- W4214584771 cites W1979335806 @default.
- W4214584771 cites W1979562553 @default.
- W4214584771 cites W1996510966 @default.
- W4214584771 cites W2001198728 @default.
- W4214584771 cites W2003426533 @default.
- W4214584771 cites W2040078764 @default.
- W4214584771 cites W2051325761 @default.
- W4214584771 cites W2082602069 @default.
- W4214584771 cites W2084354707 @default.
- W4214584771 cites W2084586309 @default.
- W4214584771 cites W2105668062 @default.
- W4214584771 cites W2107277218 @default.
- W4214584771 cites W2113231588 @default.
- W4214584771 cites W2132629607 @default.
- W4214584771 cites W2143819289 @default.
- W4214584771 cites W2156674448 @default.
- W4214584771 cites W2161861633 @default.
- W4214584771 cites W2180527932 @default.
- W4214584771 cites W2492306183 @default.
- W4214584771 cites W2650652429 @default.
- W4214584771 cites W2731784911 @default.
- W4214584771 cites W2743896081 @default.
- W4214584771 cites W2755990808 @default.
- W4214584771 cites W2770712061 @default.
- W4214584771 cites W2784371446 @default.
- W4214584771 cites W2786987313 @default.
- W4214584771 cites W2787553551 @default.
- W4214584771 cites W2790465248 @default.
- W4214584771 cites W2790968846 @default.
- W4214584771 cites W2792915048 @default.
- W4214584771 cites W2796176973 @default.
- W4214584771 cites W2796189116 @default.
- W4214584771 cites W2800840044 @default.
- W4214584771 cites W2888158672 @default.
- W4214584771 cites W2889489827 @default.
- W4214584771 cites W2904081063 @default.
- W4214584771 cites W2911125448 @default.
- W4214584771 cites W2946841069 @default.
- W4214584771 cites W2946910118 @default.
- W4214584771 cites W2950993551 @default.
- W4214584771 cites W2955139943 @default.
- W4214584771 cites W2964471257 @default.
- W4214584771 cites W2967150722 @default.
- W4214584771 cites W2982116988 @default.
- W4214584771 cites W2983017086 @default.
- W4214584771 cites W3003345262 @default.
- W4214584771 cites W3009367327 @default.
- W4214584771 cites W3014178090 @default.
- W4214584771 cites W3019294197 @default.
- W4214584771 cites W3027428490 @default.
- W4214584771 cites W3087992083 @default.
- W4214584771 cites W3090150457 @default.
- W4214584771 cites W3090297365 @default.
- W4214584771 cites W3094756389 @default.
- W4214584771 cites W3110799778 @default.
- W4214584771 cites W3110833960 @default.
- W4214584771 cites W3128646645 @default.
- W4214584771 cites W3141010425 @default.
- W4214584771 cites W4249713142 @default.
- W4214584771 doi "https://doi.org/10.1021/acs.jnatprod.1c00761" @default.
- W4214584771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35200033" @default.
- W4214584771 hasPublicationYear "2022" @default.
- W4214584771 type Work @default.
- W4214584771 citedByCount "3" @default.
- W4214584771 countsByYear W42145847712022 @default.
- W4214584771 countsByYear W42145847712023 @default.
- W4214584771 crossrefType "journal-article" @default.
- W4214584771 hasAuthorship W4214584771A5018720472 @default.
- W4214584771 hasAuthorship W4214584771A5024319971 @default.
- W4214584771 hasAuthorship W4214584771A5045399243 @default.
- W4214584771 hasAuthorship W4214584771A5050935789 @default.
- W4214584771 hasAuthorship W4214584771A5052403623 @default.
- W4214584771 hasAuthorship W4214584771A5057226699 @default.
- W4214584771 hasAuthorship W4214584771A5065499122 @default.
- W4214584771 hasAuthorship W4214584771A5066954860 @default.
- W4214584771 hasAuthorship W4214584771A5070696076 @default.
- W4214584771 hasAuthorship W4214584771A5075295556 @default.
- W4214584771 hasAuthorship W4214584771A5075828120 @default.
- W4214584771 hasConcept C121608353 @default.